Efficacy of combined Use of Oxytocin and Misoprostol in reducing blood loss at cesarean sectio

Phase 1

• Conditions: post partum haemorrhage at cesarean section; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12612000095864
• Lead Sponsor: Qazvin University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

pregnant women at term (37—40 wks) gestation scheduled for either elective or emergency lower segment cesarean
section .

Exclusion Criteria

excluding criteria:Women with any risk factor
associated with an increased risk of postpartum
hemorrhage were excluded i.e. anemia (Hb8 g%), multiple gestation, antepartum hemorrhage,poly-hydramnios, two or more previous cesarean sections and/or a history of previous rupture uterus, current or previous history of significant disease including heart disease, liver, renal disorders or known coagulopathy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
changes in hemoglobin levels after delivery is assessed by laboratory assesment of Hb[Hemoglobin values will be determined both before surgery and 24 h following surgery];estimated amount of blood loss at cesarean section[The volume of blood in the suction bottle was measured, blood soaked sponges and added to volume from suction bottle during aperative period];need for additional oxytocic therapy is assesesed by surgeon request[during operative period]

Secondary Outcome Measures

Name	Time	Method
Hemodynamic variables were recorded every 5 minutes during surgery[Hemodynamic variables will be assessed by noninvasive electrocardiogram monitoring every 5 minutes during surgery]